Corticosteroid Dosing for Vasculitis Treatment

Initial Dosing by Disease Severity

The standard initial oral prednisone dose for ANCA-associated vasculitis is 0.5-1 mg/kg/day, with a typical maximum dose of 60-80 mg/day in adults, according to the BMJ 1, 2
For severe presentations with renal impairment or pulmonary hemorrhage, the American College of Rheumatology recommends initiating treatment with IV pulse methylprednisolone 500-1000 mg/day for 3 days before transitioning to oral therapy 3
After IV pulse therapy, the KDIGO guidelines recommend transitioning to oral prednisone at 1 mg/kg/day, with a maximum dose of 60-80 mg/day in adults 1, 2
In children, the initial oral prednisone dose is 1-2 mg/kg/day, generally up to 60 mg/day, as recommended by the American Academy of Pediatrics 4

The PEXIVAS trial demonstrated that reduced-dose glucocorticoid regimens with more rapid tapering are as effective as standard regimens but safer, according to the BMJ 1, 2
The British Society for Rheumatology recommends a "rapid reduction" after initial dosing, though their taper rate remains slower than the PEXIVAS reduced-dose regimen 1
The target reduction is to 15-20 mg/day within 2-3 months, as recommended by the European League Against Rheumatism 6

Glucocorticoid-related infections are a leading cause of death in the first year of vasculitis treatment, making dose minimization essential, according to the American College of Rheumatology 3
The National Osteoporosis Foundation recommends implementing bone protection therapy for all patients on prolonged steroid treatment 6
The American College of Rheumatology recommends considering steroid-sparing agents early in severe disease to reduce cumulative glucocorticoid exposure 1, 3

For drug-induced leukocytoclastic vasculitis, the initial high dose of 1 mg/kg/day should be maintained for approximately one month before tapering, as recommended by the European League Against Rheumatism 6
For HSP vasculitis with significant renal involvement, the initial high dose should be maintained for 2-4 weeks, with total treatment duration ranging from 4 weeks to several months depending on response, according to the American Academy of Pediatrics 5